IP Cases — 2024
4,762 decisions across all jurisdictions
Page 20 of 159 · 4,762 total
Garmin International, Inc. v.Cardiacsense LTD
Garmin and Cardiacsense settled their IPR dispute over patent 7,980,998, leading the PTAB to terminate the proceeding without a final decision.
Green Revolution Cooling, Inc. v.Midas Green Technologies, LLC
Midas Green Technologies seeks Director Review to overturn the PTAB’s decision instituting an IPR on its immersion‑cooling patent, arguing the Board misapplied Fintiv factors and recent case law.
Digital Global Systems, Inc. v.DeepSig Inc.
DeepSig rebuts Digital Global Systems’ attempt to introduce new claim‑construction arguments in a PTAB Director Review request, arguing the Board’s original claim interpretations were correct and that instituting a dependent claim without an unpatentable independent claim is legally untenable.
Garmin International, Inc. v.Cardiacsense LTD
Garmin and Cardiacsense have jointly moved to terminate their Inter Partes Review over U.S. Patent 7,980,998 after reaching a settlement. The Board is asked to dismiss the proceeding under statutory authority.
Garmin International, Inc. v.Cardiacsense LTD
The PTAB denied Dexcowin Global’s inter partes review petition against Aribex’s portable x‑ray device patent, finding no reasonable likelihood of success on any claim. The Board rejected anticipation and obviousness arguments centered on a continuous high‑voltage DC power limitation.
Digital Global Systems, Inc. v.DeepSig Inc.
Digital Global Systems seeks Director Review of the PTAB’s denial to institute an IPR on its AI‑driven radio‑signal patent. The petitioner argues the Board misread claim language, requiring a modeled signal, and that the Jüschke and Holt references satisfy the statutory standard.
Garmin International, Inc. v.Cardiacsense LTD
Garmin and CardiacSense have settled their IPR dispute over U.S. Patent 7,980,998 and jointly request the Board keep the settlement agreement confidential, effectively moving to terminate the proceeding.
Digital Global Systems, Inc. v.DeepSig Inc.
The USPTO denied Digital Global Systems' request for Director Review of the decision that refused to institute its IPR against DeepSig. The denial leaves the original institution denial in place.
Digital Global Systems, Inc. v.DeepSig Inc.
Digital Global Systems petitions the PTAB to invalidate DeepSig’s 11,777,540 patent, asserting that its AI‑driven radio‑predistortion claims are obvious over earlier disclosures by Jüschke, Holt, and Dzierwa. The petition outlines three statutory grounds under 35 U.S.C. §103 and urges institution of the review.
Garmin International, Inc. v.Cardiacsense LTD
Garmin has filed an IPR petition challenging Cardiacsense’s ’998 patent covering swimming‑watch technology. The petition alleges lack of written description for a compass and obviousness over multiple prior‑art references.
Green Revolution Cooling, Inc. v.Midas Green Technologies, LLC
Green Revolution Cooling petitions the PTAB to invalidate claims 1‑16 of U.S. Patent 10,405,457, arguing obviousness over Best‑2008 combined with Osada and Best‑2012, and asserting that discretionary denial is unwarranted.
Green Revolution Cooling, Inc. v.Midas Green Technologies, LLC
The Director denied the institution of an IPR for Midas Green Technologies against Green Revolution Cooling, citing Fintiv factors and concerns over parallel proceedings.
Green Revolution Cooling, Inc. v.Midas Green Technologies, LLC
Green Revolution Cooling, Inc. successfully secured institution at the PTAB against Midas Green Technologies, LLC regarding claims covering appliance immersion cooling systems. The Board found that the petitioner met the burden of proof for obviousness under 35 U.S.C. § 103 based on prior art references Best-2008 and Osada.
Garmin International, Inc. v.Cardiacsense LTD
Garmin International successfully navigated the initial stages of its IPR challenge against Cardiacsense LTD's '998 patent, establishing a reasonable likelihood of prevailing on several grounds. The Board found that certain claims were not entitled to an earlier effective filing date due to insufficient written description support for a compass feature in prior applications.
Digital Global Systems, Inc. v.DeepSig Inc.
The PTAB denied institution of an IPR challenge against DeepSig Inc.'s radio communication patent (11,777,540) filed by Digital Global Systems, citing insufficient evidence that the claims were obvious over prior art.
Nalli Duraiswami Saroja (Late) (Through her son) Trading as Nalli Weaving Center v.N.Kuppuswami Chettiar
The Madras High Court dismissed an appeal filed by Nalli Duraiswami Saroja (Late) against a rectification order concerning her trademark. The court noted that despite repeated opportunities, the appellant failed to appear or prosecute the case. Consequently, the original registration was allowed to continue without challenge from the appellant's side.
Malikie Innovations Ltd. v.Respondent
1 Hamburg - Local Division UPC_CFI_555/2024 Preliminary Order of the Court of First Instance of the Unified Patent Court delivered on 18/11/2024 APPLICANT Malikie Innovations Ltd. (Claimant) - The Glasshouses GH2, 92 Georges Street Lower Dun Laoghaire - A96 VR66 - Dublin - IE Represe
YANGTZE MEMORY TECHNOLOGIES COMPANY, LTD. v.Micron Technology, Inc. et al.
Yangtze Memory Technologies (YMTC) filed an authorized response to Micron’s Director Review request, arguing the PTAB correctly upheld YMTC’s eligibility to pursue IPRs and rejected Micron’s Return Mail arguments. The Board is urged to deny Micron’s request for discretionary denial.
Yangtze Memory Technologies Company, Ltd. v.Micron Technology, Inc. et al.
Micron has filed a Request for Director Review seeking to overturn the Board’s decision to institute an IPR against YMTC, arguing the Chinese state‑owned firm is not a “person” under 35 U.S.C. §311 and that the Board should have exercised discretionary denial under §314(a).
Yangtze Memory Technologies Company, Ltd. v.Micron Technology, Inc. et al.
The PTAB granted a Director Review of the institution decision in Micron's IPR against Yangtze Memory, staying the proceedings while the Board reconsidered challenges related to foreign sovereign control and RPI disclosure.
Azurity Pharmaceuticals, Inc. v.EXELIXIS, INC.
Azurity Pharmaceuticals has filed an IPR petition seeking cancellation of claims 1‑3 of Exelixis’s U.S. Pat. 11,298,349 covering oral cabozantinib (L)-malate formulations. The petition alleges anticipation by the earlier Wilson patent and obviousness over Brown, Kubo and Remington, while arguing that discretionary denial factors do not apply.
Innoscience America, Inc. et al. v.Infineon Technologies Americas Corp.
Innoscience seeks to invalidate all 17 claims of Infineon’s 8,686,562 patent covering III‑V semiconductor electrical contacts, arguing they are anticipated or obvious over four prior‑art references.
YANGTZE MEMORY TECHNOLOGIES COMPANY, LTD. v.Micron Technology, Inc. et al.
Yangtze Memory Technologies has filed an IPR petition challenging Micron's 3D NAND patent (US 10,872,903). The petition asserts anticipation and obviousness over Ahn, Ishikawa, and Fukuzumi prior art and argues that the Board should not exercise discretionary exclusions.
Azurity Pharmaceuticals, Inc. v.EXELIXIS, INC.
Azurity Pharmaceuticals failed to convince the PTAB that EXELIXIS's drug formulation patent was unpatentable, resulting in a denial of institution for IPR2025-00210. The Board rejected anticipation arguments based on prior art family relationships and dismissed obviousness claims regarding impurity control.
Innoscience America, Inc. et al. v.Infineon Technologies Americas Corp.
The PTAB instituted the IPR challenge by Innoscience America against Infineon Technologies' patent covering semiconductor devices. The Board found a reasonable likelihood of anticipation for several claims over the prior art reference Usui, while also finding merit in the obviousness arguments.
YANGTZE MEMORY TECHNOLOGIES COMPANY, LTD. v.Micron Technology, Inc. et al.
Yangtze Memory Technologies (YMTC) successfully petitioned to challenge Micron Technology's patent, leading the Board to institute the IPR. The petitioner argued that prior art disclosed or suggested key elements of flash memory technology. This decision allows YMTC to proceed with challenging claims related to semiconductor device structures.
Yangtze Memory Technologies Company, Ltd. v.Micron Technology, Inc. et al.
The PTAB denied IPR petitions filed by Yangtze Memory Technologies (YMTC) against Micron. The denial was based not on patentability, but on YMTC's failure to satisfy its statutory duty to identify all Real Parties in Interest.
UPC Decision UPC-001163 v.Respondent
Koninklijke Philips N.V. filed an application for interim measures against Shenzhen Yunding Information Technology Co., Ltd concerning European Patent EP 3 197 316, but withdrew the application the following day. After the court confirmed the effectiveness of the withdrawal, Philips sought a 60% refund of the court fees paid. The Local Division Munich held that Rule 370(9)(b)(i) of the Rules of Procedure applies analogously to the withdrawal of an application for interim measures before completion of the written procedure, and ordered a refund of €6,600.00.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Ltd., Meril Gmbh
This decision was issued by the Local Division Munich of the Unified Patent Court's Court of First Instance concerning European Patent EP 3 646 825. The headnotes address key procedural and substantive issues including the UPC's jurisdiction over pre-1 June 2023 infringing acts, the claimant's choice of competent German local division, bifurcation and referral of counterclaims for revocation under Article 32(3b) UPCA, and the court's discretion regarding stays of infringement proceedings. The decision also addresses injunctive relief under Article 34 UPCA, the consideration of third-party and public interests under Article 64(4) UPCA, and mechanisms such as mandatory licenses and single-use licenses to address public needs.
Meril Gmbh, Meril Life Sciences Pvt Ltd. v.Respondent
This procedural order concerns an infringement action regarding European patent EP 3 646 825 before the Local Division Munich. The Defendants (Meril) filed late applications requesting the Court to approach the European Commission regarding ongoing antitrust investigations into the Claimant (Edwards Lifesciences) and to reopen the written procedure. The Court rejected the requests as untimely, finding they were filed after the closure of the written procedure and the oral hearing, and noted that no formal investigation had been opened by the European Commission.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.